中华糖尿病杂志
中華糖尿病雜誌
중화당뇨병잡지
CHINESE JOURNAL OF DIABETES
2004年
6期
413-416
,共4页
毛晓明%刘志民%石勇栓%蒋克春%王爱萍%饶亚平
毛曉明%劉誌民%石勇栓%蔣剋春%王愛萍%饒亞平
모효명%류지민%석용전%장극춘%왕애평%요아평
糖耐量受损%胰岛素抵抗%维生素C%维生素E%氧化性应激
糖耐量受損%胰島素牴抗%維生素C%維生素E%氧化性應激
당내량수손%이도소저항%유생소C%유생소E%양화성응격
Impaired glucose tolerance%Insulin resistance% Vitamin C% Vitamin E% Oxidative stress
目的 观察维生素C与维生素E联合治疗对糖耐量受损(IGT)患者糖代谢的影响. 方法以口服葡萄糖耐量试验(OGTT)筛查IGT患者159例,随机分成治疗组和对照组,治疗组予口服维生素C 500 mg/d及维生素E 200 mg/d,6个月;对照组不进行任何治疗.分别于治疗前后检测血糖(PG)及胰岛素(Ins),用稳态模型评价胰岛素抵抗指数(HOMA-IR)及胰岛细胞分泌功能指数(HOMA-β). 结果治疗组FPG、Ins及HOMA-IR较试验前及对照组均明显下降,HOMA-β无明显变化.对照组试验前后各项指标无明显变化.试验结束时,对照组有3例转为糖尿病(DM),占3.8%,治疗组无DM发生.经χ2检验两组DM的发生率差异无显著意义(χ2=3.8,P>0.05). 结论维生素C与维生素E联合应用可以改善IGT患者的糖代谢,减轻其IR.
目的 觀察維生素C與維生素E聯閤治療對糖耐量受損(IGT)患者糖代謝的影響. 方法以口服葡萄糖耐量試驗(OGTT)篩查IGT患者159例,隨機分成治療組和對照組,治療組予口服維生素C 500 mg/d及維生素E 200 mg/d,6箇月;對照組不進行任何治療.分彆于治療前後檢測血糖(PG)及胰島素(Ins),用穩態模型評價胰島素牴抗指數(HOMA-IR)及胰島細胞分泌功能指數(HOMA-β). 結果治療組FPG、Ins及HOMA-IR較試驗前及對照組均明顯下降,HOMA-β無明顯變化.對照組試驗前後各項指標無明顯變化.試驗結束時,對照組有3例轉為糖尿病(DM),佔3.8%,治療組無DM髮生.經χ2檢驗兩組DM的髮生率差異無顯著意義(χ2=3.8,P>0.05). 結論維生素C與維生素E聯閤應用可以改善IGT患者的糖代謝,減輕其IR.
목적 관찰유생소C여유생소E연합치료대당내량수손(IGT)환자당대사적영향. 방법이구복포도당내량시험(OGTT)사사IGT환자159례,수궤분성치료조화대조조,치료조여구복유생소C 500 mg/d급유생소E 200 mg/d,6개월;대조조불진행임하치료.분별우치료전후검측혈당(PG)급이도소(Ins),용은태모형평개이도소저항지수(HOMA-IR)급이도세포분비공능지수(HOMA-β). 결과치료조FPG、Ins급HOMA-IR교시험전급대조조균명현하강,HOMA-β무명현변화.대조조시험전후각항지표무명현변화.시험결속시,대조조유3례전위당뇨병(DM),점3.8%,치료조무DM발생.경χ2검험량조DM적발생솔차이무현저의의(χ2=3.8,P>0.05). 결론유생소C여유생소E연합응용가이개선IGT환자적당대사,감경기IR.
Objective To observe the effects of vitamin(Vit) C and vit E combination therapy on glucose metabolism in impaired glucose tolerance (IGT) patients Methods 159 patients with IGT [fasting plasma glucose (FPG)<7 0 mmol/L and 2 h plasma glucose (PG2 h)≥7 8 mmol/L<11 1 mmol/L] were diagnosed by standard oral glucose tolerance test (OGTT) The patients were randomized into treatment(T, n =81) and control(C, n =78) groups The T group were treated with vit C (500 mg/d) and vit E (200 mg/d) for 6 months The C group had not any treatment The FPG and insulin were measured The insulin resistance (HOMA IR) and β cell function (HOMA β) were evaluated by the homeostasis model Results FPG, insulin and HOMA IR were significantly reduced in T group vs C group of IGT patients Significant difference was not noted in HOMA β between the T and C groups Three new diabetic patients appeared in C group (3 8%) and none of diabetes in T group at the end of the study, P >0 05 Conclusions Conclusions vit C vit E combination therapy can improve glucose metabolism and alleviate insulin resistance in the IGT patients